ロード中...
Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
Olanzapine is an atypical antipsychotic drug, used for the management of schizophrenia and for the treatment of moderate to severe mania associated with bipolar disorder. The objective of the present randomised, crossover study was to compare the bioavailability of olanzapine 10 mg/5 ml powder for o...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3480756/ https://ncbi.nlm.nih.gov/pubmed/23112405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0250-474X.100249 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|